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Background: The influence of anaemia on outcome was not previously extensively evaluated in patients with Idiopathic Dilated Cardiomyopathy 
(DCM).
Methods: We evaluated the impact of anaemia on the outcome in large population of young patients with Idiopathic Dilated Cardiomyopathy on 
optimal medical treatment.
Were analyzed the data of 491 patients with DCM enlisted in the Trieste Heart Muscle Disease Registry between 1988-2007 (age 45±14 years, 
males 75%, NYHA III-IV 27%, LVEF 30±10%, mean Hb 14±1 g/dl, GFR 90.2±26 ml/min, ACE 95%, BB 82%). Anaemia was defined as Hb <13g/dL for 
males and <12 g/dL for females.
Results: At baseline 13% of our patients were anemic (mean Hb 12 ±1 g/dl). They had more frequently GFR < 90 ml/min (p=0.01), worse exercise 
tolerance (p=0.002) and more dilated left ventricle (p=0.001) in comparison to the patients without anaemia. During the follow-up of 134 ± 
56 months died or underwent heart transplantation 36.5% anemic patients and 28% without anaemia (p=0.05). Anaemia present at baseline 
was independent predictor of outcome (HR=1.856, p=0.014). In 47 (39%) out 122 patients with normal haemoglobin level at baseline and Hb 
determinations available for six years follow-up, new onset anaemia was observed. The patients developing anaemia had a worse survival (p=0.001). 
The new-onset of anaemia was an independent predictor of poor outcome (HR= 2.85, p=0.02).
Conclusions: The presence and the development of mild anaemia in young patients with Idiopathic DCM optimally treated with ACE inhibitors and 
Beta-blockers is frequent and is associated with a worse outcome.
